Biblio Discovery — Demo Discovery Service

12 results for "Syed Sikander Azam"

Showing 1–12 · 0.88 seconds · RSS

  1. Journal Article Full text

    Deciphering the relational dynamics of AF-2 domain of PAN PPAR through drug repurposing and comparative simulations

    Fouzia Gul; Nousheen Parvaiz; Syed Sikander Azam

    PLOS ONE, Vol. 18 No. 3 · 2023 · English · PLOS Scopus

    Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors, and their activation has been proven to treat mild liver fibrosis, reduce steatosis, inflammation, and the extrahepatic effects of chronic liver disease. Considering the significance of the PPARs, it is targeted for the…

    Also available at: DOAJ

  2. Journal Article Full text

    Senna makki and other active phytochemicals: Myths and realities behind covid19 therapeutic interventions

    Naila Zaman; Nousheen Parvaiz; Rabia Farid et al.

    PLOS ONE, Vol. 17 No. 6 · 2022 · English · PLOS Scopus

    This study aims to investigate the binding potential of chemical compounds of Senna in comparison with the experimentally tested active phytochemicals against SARS-CoV-2 protein targets to assist in prevention of infection by exploring multiple treatment options. The entire set of phytochemicals…

    Also available at: DOAJ, DOAJ

  3. Journal Article Full text

    Discovery of beta-lactamase CMY-10 inhibitors for combination therapy against multi-drug resistant Enterobacteriaceae

    Nousheen Parvaiz; Faisal Ahmad; Wenbo Yu et al.

    PLOS ONE, Vol. 16 No. 1 · 2021 · English · PLOS Scopus

    β-lactam antibiotics are the most widely used antimicrobial agents since the discovery of benzylpenicillin in the 1920s. Unfortunately, these life-saving antibiotics are vulnerable to inactivation by continuously evolving β-lactamase enzymes that are primary resistance determinants in multi-drug…

    Also available at: DOAJ

  4. Journal Article

    Molecular insights into pangenome localization and constructs design for Hemophilus influenza vaccine

    Naila Zaman; Kainat Gul; Kinza Khurram et al.

    Scientific Reports, Vol. 15 No. 1 · 2025 · English · DOAJ Scopus

    Abstract Haemophilus influenza, a major contributor to respiratory infections such as pneumonia, meningitis, sinusitis, chronic bronchitis, and acute otitis, poses a significant public health challenge, driven by rising antibiotic resistance particularly among the non-typeable H. influenza (NTHi)…

  5. Journal Article

    Dynamics of water-mediated interaction effects on the stability and transmission of Omicron

    Naila Zaman; Nousheen Parvaiz; Fouzia Gul et al.

    Scientific Reports, Vol. 13 No. 1 · 2023 · English · DOAJ Scopus

    Abstract SARS-Cov-2 Omicron variant and its highly transmissible sublineages amidst news of emerging hybrid variants strengthen the evidence of its ability to rapidly spread and evolve giving rise to unprecedented future waves. Owing to the presence of isolated RBD, monomeric and trimeric Cryo-EM…

  6. Journal Article

    Immunoinformatic and reverse vaccinology-based designing of potent multi-epitope vaccine against Marburgvirus targeting the glycoprotein

    Hassan Yousaf; Anam Naz; Naila Zaman et al.

    Heliyon, Vol. 9 No. 8 · 2023 · English · DOAJ Scopus

    Marburg virus (MARV) has been a major concern since its first outbreak in 1967. Although the deadly BSL-4 pathogen has been reported in few individuals with sporadic outbreaks following 1967, its rarity commensurate the degree of disease severity. The virus has been known to cause extreme…

  7. Journal Article Full text

    In Silico and In Vitro Study of Janus Kinases Inhibitors from Naphthoquinones

    Kamonpan Sanachai; Panupong Mahalapbutr; Lueacha Tabtimmai et al.

    Molecules, Vol. 28 No. 2 · 2023 · English · DOAJ Scopus

    Janus kinases (JAKs) are involved in numerous cellular signaling processes related to immune cell functions. JAK2 and JAK3 are associated with the pathogenesis of leukemia and common lymphoid-derived illnesses. JAK2/3 inhibitors could reduce the risk of various diseases by targeting this pathway…